Navigation Links
Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific
Date:11/21/2013

NATICK, Mass., Nov. 21, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the appointment of Susan (Susie) Vissers Lisa as vice president, Investor Relations, effective December 2, 2013.  Lisa has more than 20 years of diverse financial and healthcare industry experience, including extensive knowledge of the medical technology industry.

Lisa previously served as senior director, investor relations and corporate development at Abiomed, Inc., a medical technology company that develops products that provide circulatory support.  Prior to joining Abiomed, Lisa held several roles of increasing responsibility within the Equity division at Bank of America Merrill Lynch, including head of Specialist Sales.  Additionally, Lisa spent four years as an equity research analyst covering medical technology, both at Merrill Lynch and Cowen & Co, and began her career at JP Morgan Chase & Co.

A Chartered Financial Analyst, Lisa earned a bachelor of arts degree in political science from Duke University and a master of business administration degree from New York University's Stern School of Business.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACT:  
Denise Kaigler
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dr. Susan Froshauer to join Connecticut bioscience team at CURE
2. PRA Named "Clinical Company of the Year" in National Contest for Second Year
3. Vasomedical Again Named on Deloittes Technology Fast 500 List
4. Edith Sanford Breast Cancer Foundation Named Official Charity Partner of Womens Running Series
5. ISPE Named as a Source in FDA Strategic Plan for Preventing and Mitigating Drug Shortages
6. PRA Staff Named Finalists in Clinical Researcher of the Year Competition
7. AbbVie Named a Science Top Employer
8. BioTrackTHC Named Washington States Legal Marijuana Traceability System
9. United Spinal Named Beneficiary Of Permobils 3rd Annual Charity Golf Tournament
10. XYMOGEN Named Among The Nations Fastest Growing Private Companies For The Sixth Time
11. PTS, Inc. Named to Inc. 500/5000 Fastest Growing Private Companies for Third Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation ... to support older adults suffering from the severe ... AARP and its members are committed to helping those ... AARP and AARP Foundation will match dollar-for-dollar contributions up ... aid. The matching program will be administered through AARP ...
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion ... today announced that it has received commitments from ... $15 million of the Company,s common stock in ... dedicated health care fund. The Company ... pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, ... the Office of Fair Trading (OFT) approval condition to the ... ViroPharma Incorporated (NASDAQ: VPHM).   As a result ... OFT approval, and Shire expects to complete the tender offer ... subject to the satisfaction of all of the remaining conditions ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 2011 PDI, Inc. (Nasdaq: PDII ), a ... companies, today announced the extension of a contract sales engagement ... began April 1 and will run for the balance of ... PDI of approximately $23 million. Under the program, ...
... April 4, 2011 VIVUS, Inc. (Nasdaq: VVUS ... the investigational drug QNEXA® for two years showed reductions in ... as improvements in lipid levels following significant reductions in weight ... two years. The data – additional results ...
Cached Medicine Technology:PDI Announces Contract Extension With Revenue Value of Approximately $23 Million 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3
(Date:4/14/2014)... A new study identifies a molecule that is a ... the molecule could be an important target for colorectal ... , The study of microRNA-135b (miR-135b) in two animal ... Cancer Cell and was led by researchers ... Arthur G. James Cancer Hospital and Richard J. Solove ...
(Date:4/14/2014)... 14In dense, urban centers around the world, many people ... by tall buildings that block sunlight. And as the ... closer together, the darkness will only spread. , ... corrugated, translucent panel that redirects sunlight onto narrow streets ... hung over the edge at an angle, where it ...
(Date:4/14/2014)... Using antibiotics alone to treat children with uncomplicated acute ... to less pain and fewer missed school days, according ... team at Nationwide Children,s Hospital and published online April ... of Surgeons , is the first prospective study on ... the United States. , Researchers enrolled 77 patients ...
(Date:4/14/2014)... it comes to the cost and quality of hospital ... best care when they are treated in units that ... their current job, according to a study from researchers ... School. The study was published in the current issue ... , The review of more than 900,000 patient ...
(Date:4/11/2014)... insights into the processes that control brain cell production ... and other brain-related disorders. , Scientists have gained new ... that controls how and when nerve and brain cells ... to develop and keeps it healthy. Their findings could ... of control, which is a fundamental characteristic of many ...
Breaking Medicine News(10 mins):Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2
... ... ... ... ...
... ... CyberKnife patients in February 2010, , ... Chicago (PRWEB) February 22, 2010 -- Accelitech LLC ... New Brunswick, NJ, a hospital-based facility operated by Saint Peter’s University Hospital. The ...
... ... ... , ... AAPA honors U.S. Surgeon General Regina Benjamin for commitment to patient care , ...
... ... of the RDX storage technology include industry leaders Dell, Fujitsu, Hitachi, HP, IBM, Imation, Maxell, ... ... announced that Maxell , a technology and marketing leader in premium data storage media ...
... ... proudly offer lead commission on submitted and completed applications as well as multiple tiers of ... advertising partner today and start earning some of the highest affiliate commissions in the financial ... Orem, UT ...
... ... create an opportunity for millions of PowerPoint and Keynote users to up their game ... Santa Clara, ... Ed Kaim unveiled SpeakFlow™, a suite of tools for creating, managing, and delivering non-linear ...
Cached Medicine News:Health News:AppDynamics Announces General Availability of AppDynamics v2.0 2Health News:AppDynamics Announces General Availability of AppDynamics v2.0 3Health News:AppDynamics Announces General Availability of AppDynamics v2.0 4Health News:AppDynamics Announces General Availability of AppDynamics v2.0 5Health News:AppDynamics Announces General Availability of AppDynamics v2.0 6Health News:AppDynamics Announces General Availability of AppDynamics v2.0 7Health News:AppDynamics Announces General Availability of AppDynamics v2.0 8Health News:AppDynamics Announces General Availability of AppDynamics v2.0 9Health News:Accelitech's 2nd New Jersey CyberKnife Site Commences Operations 2Health News:Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care 2Health News:Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care 3Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 2Health News:Maxell Joins RDX Storage Alliance to Support Growing Storage Professionals' Community 3Health News:Check City Announces New Payday Affiliate Campaign Through Partnership With The Share A Sale Affiliate Network 2Health News:Check City Announces New Payday Affiliate Campaign Through Partnership With The Share A Sale Affiliate Network 3Health News:SharpLogic Announces Launch Of SpeakFlow Non-Linear Presentation Suite At SpeakFlow.com 2Health News:SharpLogic Announces Launch Of SpeakFlow Non-Linear Presentation Suite At SpeakFlow.com 3
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: